Advanced ultrasonic antimicrobial treatment systems designed to reduce Healthcare Associated Infections (HAIs) through continuous, surface-bonded protection that works around the clock.
A fundamental challenge facing healthcare systems worldwide. We believe the answer lies in continuous, surface-level antimicrobial protection that works around the clock — mechanically destroying pathogens without chemical resistance.
Infections patients acquire while receiving medical treatment — caused by bacteria, viruses, or fungi. They represent one of the most frequent adverse events during health care delivery.
HAIs, many caused by multidrug-resistant organisms, harm patients, visitors and health workers and are a significant burden to health systems worldwide.
A worldwide crisis affecting millions, with the heaviest toll on lower-income countries.
1 in 31 hospital patients in the US has a HAI on any given day (CDC)
1 in 43 nursing home residents
11% of general surgical patients develop infection within 30 days
Infection prevention and control depend on resources. Lower-income countries experience a higher frequency of HAIs and suffer worse outcomes. Disparity remains critical.
Multiple interconnected factors contribute to the spread of healthcare associated infections — some are modifiable.
Patients in care are less able to fight off infections, making them highly vulnerable.
Microorganisms that normally live on and within the human body become opportunistic.
Surgical sites, catheters, and ventilators create direct pathways for pathogens.
ModifiableContact with contaminated surfaces, droplet and aerosolised transmission.
ModifiableHealthcare personnel practice and failure of infection control play a significant role. Hand hygiene compliance remains suboptimal worldwide.
The majority of countries met only 50% of the WHO's minimum requirements for infection prevention and control.
Mechanical ventilation systems provide ideal conditions for microbial growth, bringing compromised air into public spaces, wards, patient triage and treatment rooms. Even with the highest level of manual cleaning, surfaces remain at continual risk of contamination and microbial transference.
Improve infection prevention and control within healthcare settings
Help to reduce Healthcare Associated Infections
Education, monitoring, quality improvement, and scrutiny of IPC
For all hospital stakeholders through simple, effective treatment
Advanced ultrasonic technology transforming antimicrobial treatment from intermittent to continuous protection.
ZoonEx uses ultrasonic dispersal to move an antimicrobial liquid (Z71) into the ductwork of air conditioning systems, engaging the existing system's air intake path as the mode of transport.
The ultrasonic dispersal changes the liquid to less than 100 microns. As it moves through the system, molecules adhere to the interior of the ductwork, forming a covalent bond with the surface.
As it dries, it forms a bed of miniature spikes containing a nitrogen molecule. The nitrogen positively charges the spike. Most germs are negatively charged — like strong magnets, pathogens are attracted to treated surfaces.
Mono molecular layer binds permanently to ductwork surfaces
Active sanitiser — initial kill then continues working dry for extended periods
Antibacterial pins pierce pathogens causing cell degradation and death
Destroys pathogens via lysis — no chemical resistance possible
Zoono Z-71 Microbe Shield and Zoono GermFree24 tested successfully against Vaccinia — the 'mothership' of enveloped viruses, used as a surrogate for testing against other enveloped viruses.
*Full list available upon request
UK Standard for Mechanical Disinfection — All component parts CE marked and readily available.
Collaborative testing with NHS Wales to validate ZoonEx efficacy in real-world healthcare environments.
A&E waiting area — real-world data collection for pre- and post-treatment regimens.
HAIs continue to be a global burden, causing long-lasting negative effects on people, families, communities, healthcare providers, and global health.
Infection prevention and control measures exist but are imperfect — they require improvement in long-term effectiveness, continuity, and reliability of services.
We want to reduce adverse outcomes for patients and the costs associated — for both the person and the system providing care.
We can make integrated, meaningful and long-term improvements in existing IPC programmes without impeding on existing protocols.
A full list of references is available. Many are from the 'Global Report on Infection Prevention and Control 2024' by the WHO, which analysed IPC measures globally. We have quantitative evaluation data from labs on the efficacy of Zoono products in medical settings to support our claims.
Reach out to discuss how ZoonEx can help your healthcare facility reduce HAIs.